These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 33508126)

  • 1. Genome-wide methylation profiling of glioblastoma cell-derived extracellular vesicle DNA allows tumor classification.
    Maire CL; Fuh MM; Kaulich K; Fita KD; Stevic I; Heiland DH; Welsh JA; Jones JC; Görgens A; Ricklefs T; Dührsen L; Sauvigny T; Joosse SA; Reifenberger G; Pantel K; Glatzel M; Miklosi AG; Felce JH; Caselli M; Pereno V; Reimer R; Schlüter H; Westphal M; Schüller U; Lamszus K; Ricklefs FL
    Neuro Oncol; 2021 Jul; 23(7):1087-1099. PubMed ID: 33508126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic potential of extracellular vesicles in meningioma patients.
    Ricklefs FL; Maire CL; Wollmann K; Dührsen L; Fita KD; Sahm F; Herold-Mende C; von Deimling A; Kolbe K; Holz M; Bergmann L; Fuh MM; Schlüter H; Alawi M; Reimer R; Peine S; Glatzel M; Westphal M; Lamszus K
    Neuro Oncol; 2022 Dec; 24(12):2078-2090. PubMed ID: 35551407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of technical and clinical utility of a bead-based flow cytometry platform for multiparametric phenotyping of CNS-derived extracellular vesicles.
    Brahmer A; Geiß C; Lygeraki A; Neuberger E; Tzaridis T; Nguyen TT; Luessi F; Régnier-Vigouroux A; Hartmann G; Simon P; Endres K; Bittner S; Reiners KS; Krämer-Albers EM
    Cell Commun Signal; 2023 Oct; 21(1):276. PubMed ID: 37803478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients.
    Figueroa JM; Skog J; Akers J; Li H; Komotar R; Jensen R; Ringel F; Yang I; Kalkanis S; Thompson R; LoGuidice L; Berghoff E; Parsa A; Liau L; Curry W; Cahill D; Bettegowda C; Lang FF; Chiocca EA; Henson J; Kim R; Breakefield X; Chen C; Messer K; Hochberg F; Carter BS
    Neuro Oncol; 2017 Oct; 19(11):1494-1502. PubMed ID: 28453784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease.
    Mallawaaratchy DM; Hallal S; Russell B; Ly L; Ebrahimkhani S; Wei H; Christopherson RI; Buckland ME; Kaufman KL
    J Neurooncol; 2017 Jan; 131(2):233-244. PubMed ID: 27770278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MoS
    Jalali M; Del Real Mata C; Montermini L; Jeanne O; I Hosseini I; Gu Z; Spinelli C; Lu Y; Tawil N; Guiot MC; He Z; Wachsmann-Hogiu S; Zhou R; Petrecca K; Reisner WW; Rak J; Mahshid S
    ACS Nano; 2023 Jul; 17(13):12052-12071. PubMed ID: 37366177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Oncogenic EGFRvIII on the Proteome of Extracellular Vesicles Released from Glioblastoma Cells.
    Choi D; Montermini L; Kim DK; Meehan B; Roth FP; Rak J
    Mol Cell Proteomics; 2018 Oct; 17(10):1948-1964. PubMed ID: 30006486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comprehensive Proteomic SWATH-MS Workflow for Profiling Blood Extracellular Vesicles: A New Avenue for Glioma Tumour Surveillance.
    Hallal S; Azimi A; Wei H; Ho N; Lee MYT; Sim HW; Sy J; Shivalingam B; Buckland ME; Alexander-Kaufman KL
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32635403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular Vesicles Released by Glioblastoma Cells Stimulate Normal Astrocytes to Acquire a Tumor-Supportive Phenotype Via p53 and MYC Signaling Pathways.
    Hallal S; Mallawaaratchy DM; Wei H; Ebrahimkhani S; Stringer BW; Day BW; Boyd AW; Guillemin GJ; Buckland ME; Kaufman KL
    Mol Neurobiol; 2019 Jun; 56(6):4566-4581. PubMed ID: 30353492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles.
    Reátegui E; van der Vos KE; Lai CP; Zeinali M; Atai NA; Aldikacti B; Floyd FP; H Khankhel A; Thapar V; Hochberg FH; Sequist LV; Nahed BV; S Carter B; Toner M; Balaj L; T Ting D; Breakefield XO; Stott SL
    Nat Commun; 2018 Jan; 9(1):175. PubMed ID: 29330365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular Vesicles from Neurosurgical Aspirates Identifies Chaperonin Containing TCP1 Subunit 6A as a Potential Glioblastoma Biomarker with Prognostic Significance.
    Hallal S; Russell BP; Wei H; Lee MYT; Toon CW; Sy J; Shivalingam B; Buckland ME; Kaufman KL
    Proteomics; 2019 Jan; 19(1-2):e1800157. PubMed ID: 30451371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global extracellular vesicle proteomic signature defines U87-MG glioma cell hypoxic status with potential implications for non-invasive diagnostics.
    Indira Chandran V; Welinder C; Gonçalves de Oliveira K; Cerezo-Magaña M; Månsson AS; Johansson MC; Marko-Varga G; Belting M
    J Neurooncol; 2019 Sep; 144(3):477-488. PubMed ID: 31414377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating extracellular vesicles as biomarker for diagnosis, prognosis, and monitoring in glioblastoma patients.
    Ricklefs FL; Wollmann K; Salviano-Silva A; Drexler R; Maire CL; Kaul MG; Reimer R; Schüller U; Heinemann S; Kolbe K; Mummert T; Glatzel M; Peine S; Gempt J; Westphal M; Dührsen L; Lamszus K
    Neuro Oncol; 2024 Jul; 26(7):1280-1291. PubMed ID: 38567448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gliomatosis cerebri: no evidence for a separate brain tumor entity.
    Herrlinger U; Jones DTW; Glas M; Hattingen E; Gramatzki D; Stuplich M; Felsberg J; Bähr O; Gielen GH; Simon M; Wiewrodt D; Schabet M; Hovestadt V; Capper D; Steinbach JP; von Deimling A; Lichter P; Pfister SM; Weller M; Reifenberger G
    Acta Neuropathol; 2016 Feb; 131(2):309-319. PubMed ID: 26493382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ExRNA in Biofluids as Biomarkers for Brain Tumors.
    Rennert RC; Hochberg FH; Carter BS
    Cell Mol Neurobiol; 2016 Apr; 36(3):353-60. PubMed ID: 26993514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High density DNA methylation array is a reliable alternative for PCR-based analysis of the MGMT promoter methylation status in glioblastoma.
    Braczynski AK; Capper D; Jones DTW; Schittenhelm J; Stichel D; von Deimling A; Harter PN; Mittelbronn M
    Pathol Res Pract; 2020 Jan; 216(1):152728. PubMed ID: 31784096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioma-Derived miRNA-Containing Extracellular Vesicles Induce Angiogenesis by Reprogramming Brain Endothelial Cells.
    Lucero R; Zappulli V; Sammarco A; Murillo OD; Cheah PS; Srinivasan S; Tai E; Ting DT; Wei Z; Roth ME; Laurent LC; Krichevsky AM; Breakefield XO; Milosavljevic A
    Cell Rep; 2020 Feb; 30(7):2065-2074.e4. PubMed ID: 32075753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular vesicles as source for the identification of minimally invasive molecular signatures in glioblastoma.
    Rackles E; Lopez PH; Falcon-Perez JM
    Semin Cancer Biol; 2022 Dec; 87():148-159. PubMed ID: 36375777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular Vesicles in Brain Tumor Progression.
    D'Asti E; Chennakrishnaiah S; Lee TH; Rak J
    Cell Mol Neurobiol; 2016 Apr; 36(3):383-407. PubMed ID: 26993504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Pilot Proof-Of-Principle Analysis Demonstrating Dielectrophoresis (DEP) as a Glioblastoma Biomarker Platform.
    Lewis J; Alattar AA; Akers J; Carter BS; Heller M; Chen CC
    Sci Rep; 2019 Jul; 9(1):10279. PubMed ID: 31311947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.